ScholarIQanswers from OpenAlex

Assessment and management of retinopathy of prematurity in the era of anti-vascular endothelial growth factor (VEGF)

PaperCitations, authors & open-access status

Assessment and management of retinopathy of prematurity in the era of anti-vascular endothelial growth factor (VEGF) is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Assessment and management of retinopathy of prematurity in the era of anti-vascular endothelial growth factor (VEGF) have?

ScholarIQcitation count

Assessment and management of retinopathy of prematurity in the era of anti-vascular endothelial growth factor (VEGF) has 94 citations in the OpenAlex counts ScholarIQ stores.

When was Assessment and management of retinopathy of prematurity in the era of anti-vascular endothelial growth factor (VEGF) published?

ScholarIQyear

Assessment and management of retinopathy of prematurity in the era of anti-vascular endothelial growth factor (VEGF) has 2021 year in the ScholarIQ index.

What is the open-access status of Assessment and management of retinopathy of prematurity in the era of anti-vascular endothelial growth factor (VEGF)?

ScholarIQoa status

Assessment and management of retinopathy of prematurity in the era of anti-vascular endothelial growth factor (VEGF) has closed oa status in the ScholarIQ index.

What is the DOI of Assessment and management of retinopathy of prematurity in the era of anti-vascular endothelial growth factor (VEGF)?

ScholarIQdoi

The DOI for Assessment and management of retinopathy of prematurity in the era of anti-vascular endothelial growth factor (VEGF) is on the source record.

What is the PMID of Assessment and management of retinopathy of prematurity in the era of anti-vascular endothelial growth factor (VEGF)?

ScholarIQpmid

The PMID for Assessment and management of retinopathy of prematurity in the era of anti-vascular endothelial growth factor (VEGF) is on the source record.

What is the OpenAlex record for Assessment and management of retinopathy of prematurity in the era of anti-vascular endothelial growth factor (VEGF)?

ScholarIQopenalex

The OpenAlex for Assessment and management of retinopathy of prematurity in the era of anti-vascular endothelial growth factor (VEGF) is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial